Balanced news tone
News Sentiment
AVTR sentiment intelligence
Avantor Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
74/100 classification confidence.
directly relevant articles
high-authority source matches
+0.7% over one week, +10.6% over four weeks, trend inactive, and below fair value.
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 15 Jul 2026 16:10
- Source
- Market source
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 13:01
- Source
- Zacks
Avantor Inc (AVTR) Stock Up 6.9% and Still Undervalued -- GF Sco
Avantor Inc's (AVTR) stock rose 6.9% to $11.29, yet is still considered undervalued with a GF Value™ of $18.44, indicating a 38.8% upside. Despite the undervaluation, GuruFocus issues a "Possible Value Trap" warning, urging caution. Insider buying activity, totaling $0.3 million
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 14 Jul 2026 22:47
- Source
- GuruFocus
Avantor Jumps 6.2% Amid Sector-Wide Rally
Avantor (AVTR) surged 6.2% to $11.21 on Tuesday, participating in a broad sector-wide rally for medical instruments and supplies stocks. The movement was attributed to widespread buying pressure and institutional capital rotation rather than company-specific news, with peers like
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 14 Jul 2026 21:10
- Source
- AlphaStreet
Avantor (AVTR) Stabilizes Under New CEO, But Is The Valuation Case Still Too Rich?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 13:52
- Source
- simplywall.st
Avantor's NuSil Brand Expands HIV Prevention Collaboration With Population Council
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 14 Jul 2026 13:26
- Source
- MT Newswires
Avantor expands partnership for HIV prevention ring development By Investing.com
Avantor has expanded its collaboration with the Population Council to develop a three-month dapivirine vaginal ring for HIV prevention. This ring, utilizing Avantor's NuSil brand silicones, aims to reduce the required number of rings annually. The three-month version has been sub
- Tone
- Positive 63/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 12:43
- Source
- Investing.com Canada
Avantor NuSil Expands Three-Month HIV Ring Partnership | AVTR Stock News
Avantor's NuSil brand has expanded its partnership with the Population Council to develop a new three-month dapivirine vaginal ring for HIV prevention. This next-generation ring aims to improve adherence, convenience, and affordability by reducing the required annual usage from t
- Tone
- Positive 63/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 11:43
- Source
- Stock Titan
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
Avantor's NuSil® brand has expanded its partnership with the Population Council to develop a new three-month dapivirine vaginal ring for HIV prevention. This next-generation ring aims to improve adherence and convenience by requiring fewer applications per year, lowering costs, a
- Tone
- Positive 71/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 11:43
- Source
- PR Newswire
Price to earnings forward of Avantor, Inc. – LSX:A2PJN6
This article provides financial information for Avantor, Inc. (LSX:A2PJN6) on TradingView, focusing specifically on its price-to-earnings forward metric. The content highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. It serves
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 17:40
- Source
- TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside
Avantor, Inc.'s average 12-month price target has been increased to $10.31 from $10.19 by 16 analysts, with forecasts ranging from $7 to $19 per share. This updated target suggests a 1% potential downside based on the Jul. 10 closing price. The consensus rating for AVTR remains "
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 13 Jul 2026 16:40
- Source
- TradingView
BofA Securities Adjusts Avantor Price Target to $12 From $10
BofA Securities has revised its price target for Avantor (NYSE:AVTR) shares, increasing it to $12 from the previous $10. The firm has maintained its "Neutral" rating on the company's stock.
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 15:40
- Source
- Moomoo
Avantor (AVTR) Gains Traction Under New Management
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 14:29
- Source
- Market source
Enterprise value to EBITDA forward of Avantor, Inc. – LSX:A2PJN6
This article provides the enterprise value to EBITDA forward for Avantor, Inc. (LSX:A2PJN6) on TradingView. It highlights the company's financial data available on the platform, indicating that the market for this financial instrument is currently closed. The content primarily se
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 10:12
- Source
- TradingView
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) concerning possible corporate wrongdoing by its officers and/or directors. The firm encourages shareholders who purchased Avantor securities before March 5, 2024, and still hold
- Tone
- Negative 28/100
- Event
- Regulatory and legal
- Published
- 12 Jul 2026 11:00
- Source
- ACCESS Newswire
Investors in Avantor, Inc. (AVTR): Protect Your Rights – Contact Levi & Korsinsky Before December 29, 2025
Levi & Korsinsky LLP has filed a class action securities lawsuit against Avantor, Inc. (AVTR) on behalf of investors who suffered losses between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor made false statements regarding its competitive positioning and n
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 12 Jul 2026 01:10
- Source
- The National Law Review
Avantor stock reflects steady life sciences demand amid global biosciences expansion
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 10 Jul 2026 19:15
- Source
- Ad-hoc-news.de
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
Avantor (AVTR) stock is positioned for growth due to its strong product portfolio, strategic deals, and ongoing cost transformation efforts, despite a 14.8% year-to-date loss. The company anticipates improved customer engagement and revenue visibility, driven by new business wins
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 10 Jul 2026 17:24
- Source
- Market source
Avantor Inc (AVTR) Stock Up 7.7% and Still Undervalued -- GF Sco
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:00
- Source
- GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (AVTR) regarding corporate wrongdoing. The firm encourages investors who purchased Avantor securities prior to March 5, 2024, and still hold them, to join the investigation. The representat
- Tone
- Negative 28/100
- Event
- Regulatory and legal
- Published
- 09 Jul 2026 11:00
- Source
- ACCESS Newswire
Avantor Price Target Raised to $11.00/Share From $9.00 by Citigroup
Citigroup has increased its price target for Avantor (NYSE:AVTR) to $11.00 per share, up from the previous target of $9.00. This adjustment reflects an updated outlook from the analytical firm regarding Avantor's stock performance.
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 08 Jul 2026 23:43
- Source
- Moomoo
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 15:54
- Source
- PR Newswire
Avantor Is Maintained at Neutral by Citigroup
Citigroup has maintained its Neutral rating on Avantor. This indicates that the analyst firm believes the stock is likely to perform in line with the market, with no strong recommendation for buying or selling.
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 16:39
- Source
- Moomoo
Avantor Inc focuses on life sciences growth while investors monitor its Nasdaq listing
Avantor Inc (AVTR) is a global supplier of critical products and services for the life sciences and advanced technology sectors, with its stock listed on Nasdaq. The company's business is centered on laboratory workflows and bioprocessing solutions, supporting research, developme
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 07 Jul 2026 22:54
- Source
- AD HOC NEWS
Is Avantor (AVTR) Undervalued As Hedge Funds Add Ahead Of Q2 Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 22:33
- Source
- simplywall.st
Avantor, Inc. (AVTR) Stock Analysis: Navigating a Healthcare Giant with a $7.05 Billion Market Cap
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 09:17
- Source
- DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Avantor, Inc. (AVTR) for potential corporate wrongdoing. The firm is encouraging investors who purchased Avantor securities before March 5, 2024, and still hold them, to join the investigation. Bronstein, Gewir
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 06 Jul 2026 02:11
- Source
- ACCESS Newswire
Is Avantor (AVTR) Stock Cheap After A 71% Five Year Fall?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Jul 2026 07:00
- Source
- Market source
Does Hedge Fund Accumulation Ahead of Earnings Call Reframe Avantor’s (AVTR) Institutional Confidence Story?
Ahead of its Q2 2026 earnings release on July 29, Avantor (AVTR) has seen a significant increase in holdings by institutional investors, including several hedge funds like Greenhaven Associates. This renewed institutional interest is seen as a key indicator of confidence in the c
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 16:39
- Source
- Market source
AVTR Shareholders Have Opportunity to Lead Avantor, Inc. Class Ac
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Avantor, Inc. (NYSE:AVTR) and its officers, alleging violations of federal securities laws. The lawsuit claims that Avantor issued materially false and misleading statements about its competitive position
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 03 Jul 2026 22:41
- Source
- The National Law Review